NMDA receptor within nucleus accumbens shell regulates propofol self‐administration through D1R/ERK/CREB signalling pathway

Abstract

AbstractAddictive properties of propofol have been demonstrated in both humans and animals. The nucleus accumbens (NAc) shell (NAsh) in the brain, along with the interactions between N‐methyl‐D‐aspartate receptor (NMDAR) and the dopamine D1 receptor (D1R), as well as their downstream ERK/CREB signalling pathway in the NAc, are integral in regulating reward‐seeking behaviour. Nevertheless, it remains unclear whether NMDARs and the NMDAR‐D1R/ERK/CREB signalling pathway in the NAsh are involved in mediating propofol addiction. To investigate it, we conducted experiments with adult male Sprague–Dawley rats to establish a model of propofol self‐administration behaviour. Subsequently, we microinjected D‐AP5 (a competitive antagonist of NMDARs, 1.0–4.0 μg/0.3 μL/site) or vehicle into bilateral NAsh in rats that had previously self‐administered propofol to examine the impact of NMDARs within the NAsh on propofol self‐administration behaviour. Additionally, we examined the protein expressions of NR2A and NR2B subunits, and the D1R/ERK/CREB signalling pathways within the NAc. The results revealed that propofol administration behaviour was enhanced by D‐AP5 pretreatment in NAsh, accompanied by elevated expressions of phosphorylation of NR2A (Tyr1246) and NR2B (Tyr1472) subunits. There were statistically significant increases in the expressions of D1Rs, as well as in the phosphorylated ERK1/2 (p‐ERK1/2) and CREB (p‐CREB). This evidence substantiates a pivotal role of NMDARs in the NAsh, with a particular emphasis on the NR2A and NR2B subunits, in mediating propofol self‐administration behaviour. Furthermore, it suggests that this central reward processing mechanism may operate through the NMDAR‐D1R/ERK/CREB signal transduction pathway.